Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin: dosing and dilution.

Gerard E Francisco1

  • 1Physical Medicine and Rehabilitation Alliance, Baylor College of Medicine/University of Texas, Houston, Texas, USA.

American Journal of Physical Medicine & Rehabilitation
|September 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Leucine Supplementation Impact Post-Stroke Sarcopenia?: A Review of Evidence and Clinical Implications.

American journal of physical medicine & rehabilitation·2026
Same author

Factors Influencing the Selection of Botulinum Toxin Preparations for the Management of Spasticity.

American journal of physical medicine & rehabilitation·2026
Same author

Driving Change in Rehabilitation Practice: Expert Insights and Strategic Direction for Integrating ISPRM's Clinical Functioning Information Tool (ClinFIT) in Clinical Practice and Research.

American journal of physical medicine & rehabilitation·2026
Same author

The Many Dimensions of Spasticity: From Lived Experience to Advanced Care.

Physical medicine and rehabilitation clinics of North America·2026
Same author

Analysis of Candidate Performance in the Brain Injury Medicine Subspecialty Certification Examination.

American journal of physical medicine & rehabilitation·2026
Same author

A phenomenological approach to spastic movement disorders: an international expert panel consensus.

Journal of neurology·2026
Same journal

Patterns of Outcome Measure Utilization in Stroke Rehabilitation Lower Extremity Trials Conducted in Low-to-Middle versus High-Income Countries.

American journal of physical medicine & rehabilitation·2026
Same journal

Response to the Letter to the Editor on "Comparison of Preinjury and Clinical Characteristics Between Adolescents With Sport-Related Concussion and Nonsport-Related Concussion Presenting to a Specialty Concussion Clinic".

American journal of physical medicine & rehabilitation·2026
Same journal

Spinal Schwannoma Mimicking Discogenic Low Back Pain: A Case Highlighting Valsalva-Induced Provocation.

American journal of physical medicine & rehabilitation·2026
Same journal

Bayesian Thinking in Rehabilitation Research.

American journal of physical medicine & rehabilitation·2026
Same journal

Fibrocartilaginous Embolism Presenting as Isolated L2-3 Radiculopathy without Spinal Cord Infarction.

American journal of physical medicine & rehabilitation·2026
Same journal

Management of Phantom Limb Pain Following Amputation in Pediatrics.

American journal of physical medicine & rehabilitation·2026
See all related articles

Botulinum toxin injections are increasingly used for muscle hypertonia in the US, though not FDA-approved for spasticity. This review focuses on dosing and dilution practices for botulinum toxin treatments in adults.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Botulinum toxin injections are gaining popularity for treating muscle hypertonia in the United States.
  • Despite widespread use for spasticity, botulinum toxin lacks formal FDA approval for this indication.
  • Existing FDA-approved uses include cervical dystonia for botulinum toxin type A (Botox) and type B (Myobloc).

Purpose of the Study:

  • To review current clinical practices regarding the dosing and dilution of botulinum toxin for adult spastic hypertonia.
  • To highlight the impact of dosing and dilution on treatment outcomes, based on available literature.

Main Methods:

  • Review of key articles and selected abstracts on botulinum toxin use for spastic hypertonia.
  • Emphasis on studies addressing clinical practices related to dosing and dilution.

Related Experiment Videos

Main Results:

  • Botulinum toxin's efficacy in managing spastic hypertonia is generally accepted.
  • Published studies establishing the impact of specific dosing and dilution protocols on treatment outcomes are limited.
  • Current clinical practices concerning dosing and dilution are not consistently supported by robust evidence.

Conclusions:

  • Further research is needed to establish evidence-based guidelines for botulinum toxin dosing and dilution in spasticity management.
  • Standardization of these parameters could optimize treatment efficacy and patient outcomes.
  • Understanding current practices is crucial for guiding future research and clinical application.